Estudio comparativo de las habilidades motoras, de niños zurdos y diestros

Tesis (Profesor de Educación Física para la Educación General Básica, Licenciado en Educación)Señalar las dificultades coordinativas de los alumnos varones zurdos del NB2, respecto al lanzamiento en el deporte Balonmano. Medir y comparar las habilidades coordinativas del lanzamiento, en el deporte Balonmano, correspondiente a NB2 (4° Básico)

Sacubitril/Valsartan in Daily Clinical Practice: Data From a Prospective Registry

Sacubitril/valsartan (SV) is a new therapy in heart failure with reduced ejection fraction. Our aim was to determine the efficacy and safety of this drug daily clinical practice. We performed a multicenter registry in 10 hospitals. All patients who started SV from October 2016 to March 2017 on an outpatient basis were included. A total of 427 patients started treatment with SV. Mean follow-up was 7.0 ± 0.1 months. Forty-nine patients (11.5%) discontinued SV, and 12 (2.8%) died. SV discontinuation was associated with higher cardiovascular (hazard ratio 13.22, 95% confidence interval, 6.71-15.73, P < 0.001) and all-cause mortality (hazard ratio 13.51, 95% confidence interval 3.22-56.13, P < 0.001). Symptomatic hypotension occurred in 71 patients (16.6%). Baseline N-terminal pro-B-type natriuretic peptide levels, functional class, and left ventricular ejection fraction improved at the end of follow-up in patients who continued with SV (all P values ≤0.001). This improvement was not significant in patients with SV discontinuation. SV has a good tolerability in patients from daily clinical practice. SV withdrawal in patients with heart failure and reduced ejection fraction was independently associated with increased all-cause mortality. Patients who continued with SV presented an improvement in functional class left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide levels.Sin financiación2.598 JCR (2019) Q2, 62/138 Cardiac & Cardiovascular Systems; Q3, 147/270 Pharmacology & Pharmacy0.800 SJR (2019) Q2, 110/362 Cardiology and Cardiovascular Medicine, 112/331 PharmacologyNo data IDR 2019UE

Desarrollo de capacidades para la inclusión educativa universitaria

Los ámbitos comunitarios, familiares y de género, constituyen escenarios donde se producen y reproducen cotidianamente las desigualdades, por ello desde las universidades deben ser ámbitos privilegiados para la actuación profesional. Resultan necesarias acciones tendientes a lograr mayor equidad como vía para alcanzar la igualdad, tanto en los procesos de ingreso a la educación superior como en la calidad sostenida de la educación que se ofrece, implementar un enfoque de derechos humanos, interculturalidad e inclusión social en el sentido amplio del término, que faciliten la restauración de derechos en un ambiente de paz, para lo que se deben poner en práctica acciones de igualdad de oportunidades como afirmativas. Para alcanzar estos objetivos, es necesario que los profesionales universitarios, especialmente los docentes, cuenten con conocimientos, habilidades y valores que les faciliten desarrollar la labor de intervención profesional que en este sentido se necesita. Entiéndase por intervención profesional, la actividad que desarrollan los profesionales cuando ofrecen elementos de análisis que facilitan a los sujetos necesitados de su acción, identificar las contradicciones de su entorno, elaborar alternativas de cambio y seleccionar las que consideren más pertinentes a fin de encontrar respuestas a sus necesidades

Comparison of 1-year outcome in patients with severe aorta stenosis treated conservatively or by aortic valve replacement or by percutaneous transcatheter aortic valve implantation (data from a multicenter Spanish registry)

The factors that influence decision making in severe aortic stenosis (AS) are unknown. Our aim was to assess, in patients with severe AS, the determinants of management and prognosis in a multicenter registry that enrolled all consecutive adults with severe AS during a 1-month period. One-year follow-up was obtained in all patients and included vital status and aortic valve intervention (aortic valve replacement [AVR] and transcatheter aortic valve implantation [TAVI]). A total of 726 patients were included, mean age was 77.3 ± 10.6 years, and 377 were women (51.8%). The most common management was conservative therapy in 468 (64.5%) followed by AVR in 199 (27.4%) and TAVI in 59 (8.1%). The strongest association with aortic valve intervention was patient management in a tertiary hospital with cardiac surgery (odds ratio 2.7, 95% confidence interval 1.8 to 4.1, p <0.001). The 2 main reasons to choose conservative management were the absence of significant symptoms (136% to 29.1%) and the presence of co-morbidity (128% to 27.4%). During 1-year follow-up, 132 patients died (18.2%). The main causes of death were heart failure (60% to 45.5%) and noncardiac diseases (46% to 34.9%). One-year survival for patients treated conservatively, with TAVI, and with AVR was 76.3%, 94.9%, and 92.5%, respectively, p <0.001. One-year survival of patients treated conservatively in the absence of significant symptoms was 97.1%. In conclusion, most patients with severe AS are treated conservatively. The outcome in asymptomatic patients managed conservatively was acceptable. Management in tertiary hospitals is associated with valve intervention. One-year survival was similar with both interventional strategies